Main Topics
Advanced Cellular Therapies
- Will allogeneic CAR-T cells revolutionize immunotherapy?
- Exploring the advantages of CAR NK cells over CAR-T cells
- The promise of CAR-induced pluripotent stem cells (CAR-iPSC T cells)
Immunotherapy Management
- Strategies for preventing and treating CRS/ICANS in older patients
- The role of cytokine dosage in managing CRS
- Addressing pulmonary complications after CAR-T cell treatment
Innovation in Immunotherapy
- Tackling target heterogeneity and widespread expression in CAR-T cell treatment
- Unraveling mechanisms of relapse in immunotherapy
- Understanding the significance of CAR-T cell persistence
- Exploring the value of point-of-care development
Specific Approaches
- Autologous HSCT as a platform for immunotherapy
- The current landscape of dual CAR-T cell therapies
- Allogeneic HSCT as consolidation after CAR-T cell therapy
Disease-Specific Focus
- Targeting solid tumors
- Advancements in AML immunotherapy
- First-line treatment strategies for relapsed DLBCL?
- Multiple myeloma: timing and approaches